Professional China Immunoassays - KaiBiLi COVID-19 Antigen – saliva cup – Genesis
Professional China Immunoassays - KaiBiLi COVID-19 Antigen – saliva cup – Genesis Detail:
Introduction
The KaiBiLiTM COVID-19 Antigen Rapid Test Device is an in vitro diagnostic test based on the principle of immunochromatography for the qualitative detection of 2019 Novel Coronavirus nucleocapsid protein antigens in saliva. The detection is based on the antibodies which were developed specifically recognizing and reacting with the nucleoprotein of 2019 Novel Coronavirus. It is intended to aid in the rapid diagnosis of SARS-CoV-2 infection.
COVID-19 is an acute respiratory infectious disease. People are generally susceptible. Currently, the patients infected by the novel coronavirus are the main source of infection; asymptomatic infected people can also be an infectious source. Based on the current epidemiological investigation, the incubation period is 1 to 14 days, mostly 3 to 7 days. The main symptoms including manifestations include fever, fatigue and dry cough, nasal congestion, runny nose, sore throat, myalgia and diarrhea are found in a few cases.
Features & Benefits
The KaiBiLiTM COVID-19 Antigen Rapid Test is an immunochromatographic assay for the qualitative detection of 2019 Novel Coronavirus antigens. This assay is intended for rapid screening in laboratory. This test should be conducted by trained technician, wearing appropriate personal protective equipment (PPE). The COVID-19 Antigen Rapid Test has two letters on the surface of the test device indicating test line (T) and control line (C). Test line and control line in the result window are not visible before applying any samples. The control line is a reference line which indicates the test is performing properly. The control line must appear every time when the test is performed. If SARS-CoV-2 is present in the sample, the test line would appear. The highly selective antibodies to SARS-CoV-2 are used as capture and detector in the assay. These antibodies can detect SARS-CoV-2 antigens directly, with a high accuracy.
Detection
The qualitative detection of 2019 Novel Coronavirus nucleocapsid protein antigens in saliva.
Specimen
Saliva
Limit of Detection (LoD)
2019 Novel Coronavirus: 74.8 TCID50/mL
Accuracy
Positive Percent Agreement: 96.5%
Negative Percent Agreement:97.8%
Overall Percent Agreement: 97.2%
Time to Results
Read results at 15minutes and no more than 30 minutes.
Kit Storage Conditions
2~30°C.
Contents
Description |
Qty |
COVID-19 antigen test devices |
20 |
Saliva collectors (cup and lip) |
20 |
Plastic pipettes |
20 |
Extraction tubes (with 0.5mL extraction buffer) |
20 |
Nozzles with filter |
20 |
Tube Stand |
1 |
Package Insert |
1 |
Ordering Information
Product |
Cat.No. |
Contents |
KaiBiLiTM COVID-19 Antigen |
P211140-C |
20 Tests |
Product detail pictures:
Related Product Guide:
We not only will try our greatest to offer you excellent services to just about every client, but also are ready to receive any suggestion offered by our buyers for Professional China Immunoassays - KaiBiLi COVID-19 Antigen – saliva cup – Genesis , The product will supply to all over the world, such as: Jeddah, Libya, Sri Lanka, To have much more enterprise. ompanions, we've got updated the item list and seek for optimistic co-operation. Our web-site shows the latest and complete information and facts about our merchandise list and company. For further acknowledge, our consultant service group in Bulgaria will reply to all of the inquiries and complications immediately. They're about to make their finest effort to meet buyers need. Also we support the delivery of absolutely free samples. Business visits to our business in Bulgaria and factory are generally welcome for a win-win negotiation. Hope to expertise a happy company co-operation perform with you.
By Julia from Bolivia - 2017.10.23 10:29
After the signing of the contract, we received satisfactory goods in a short term, this is a commendable manufacturer.
By Maud from Southampton - 2018.06.03 10:17